4//SEC Filing
Riebman Jerome 4
Accession 0001104659-21-034460
CIK 0001708527other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:18 PM ET
Size
7.9 KB
Accession
0001104659-21-034460
Insider Transaction Report
Form 4
Riebman Jerome
Chief Medical Officer
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2021-03-08+18,750→ 18,750 totalExercise: $14.53Exp: 2031-03-08→ CLASS A COMMON STOCK (18,750 underlying) - Award
RESTRICTED STOCK UNITS
2021-03-08+3,125→ 3,125 total→ CLASS A COMMON STOCK (3,125 underlying)
Footnotes (3)
- [F1]This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
- [F3]The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001825821
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:18 PM ET
- Size
- 7.9 KB